Global H1N1 Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global H1N1 Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global H1N1 Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Intramuscular Vaccines
1.2.3 Intranasal Vaccines
1.2.4 Intradermal Vaccines
1.3 Market Segment by Application
1.3.1 Global H1N1 Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Cervical Cancer
1.3.5 Pneumococcal
1.3.6 Hepatitis
1.3.7 Measles
1.3.8 Mumps
1.3.9 Rubella
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global H1N1 Vaccines Market Size (2017-2028)
2.1.1 Global H1N1 Vaccines Revenue (2017-2028)
2.1.2 Global H1N1 Vaccines Sales (2017-2028)
2.2 Global H1N1 Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global H1N1 Vaccines Sales by Regions (2017-2022)
2.2.2 Global H1N1 Vaccines Revenue by Regions (2017-2022)
2.3 Global H1N1 Vaccines Market Size Forecast by Region
2.3.1 Global H1N1 Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global H1N1 Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top H1N1 Vaccines Regions (Countries) Ranking by Market Size
2.5 H1N1 Vaccines Market Dynamics
2.5.1 H1N1 Vaccines Market Trends
2.5.2 H1N1 Vaccines Market Drivers
2.5.3 H1N1 Vaccines Market Challenges
2.5.4 H1N1 Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top H1N1 Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global H1N1 Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global H1N1 Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by H1N1 Vaccines Sales in 2021
3.2 Global Top Manufacturers H1N1 Vaccines by Revenue
3.2.1 Global H1N1 Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top H1N1 Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global H1N1 Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global H1N1 Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in H1N1 Vaccines as of 2021)
3.4 Global H1N1 Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers H1N1 Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into H1N1 Vaccines Market
3.7 Key Manufacturers H1N1 Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global H1N1 Vaccines Market Size by Type
4.1 Global H1N1 Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global H1N1 Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global H1N1 Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 H1N1 Vaccines Price by Type (2017-2022)
4.2 Global H1N1 Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global H1N1 Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global H1N1 Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 H1N1 Vaccines Price Forecast by Type (2023-2028)
5 Global H1N1 Vaccines Market Size by Application
5.1 Global H1N1 Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global H1N1 Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global H1N1 Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 H1N1 Vaccines Price by Application (2017-2022)
5.2 Global H1N1 Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global H1N1 Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global H1N1 Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 H1N1 Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America H1N1 Vaccines Sales Breakdown by Company
6.1.1 North America H1N1 Vaccines Sales by Company (2017-2022)
6.1.2 North America H1N1 Vaccines Revenue by Company (2017-2022)
6.2 North America H1N1 Vaccines Market Size by Type
6.2.1 North America H1N1 Vaccines Sales by Type (2017-2028)
6.2.2 North America H1N1 Vaccines Revenue by Type (2017-2028)
6.3 North America H1N1 Vaccines Market Size by Application
6.3.1 North America H1N1 Vaccines Sales by Application (2017-2028)
6.3.2 North America H1N1 Vaccines Revenue by Application (2017-2028)
6.4 North America H1N1 Vaccines Market Size by Country
6.4.1 North America H1N1 Vaccines Sales by Country (2017-2028)
6.4.2 North America H1N1 Vaccines Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe H1N1 Vaccines Sales Breakdown by Company
7.1.1 Europe H1N1 Vaccines Sales by Company (2017-2022)
7.1.2 Europe H1N1 Vaccines Revenue by Company (2017-2022)
7.2 Europe H1N1 Vaccines Market Size by Type
7.2.1 Europe H1N1 Vaccines Sales by Type (2017-2028)
7.2.2 Europe H1N1 Vaccines Revenue by Type (2017-2028)
7.3 Europe H1N1 Vaccines Market Size by Application
7.3.1 Europe H1N1 Vaccines Sales by Application (2017-2028)
7.3.2 Europe H1N1 Vaccines Revenue by Application (2017-2028)
7.4 Europe H1N1 Vaccines Market Size by Country
7.4.1 Europe H1N1 Vaccines Sales by Country (2017-2028)
7.4.2 Europe H1N1 Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific H1N1 Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific H1N1 Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific H1N1 Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific H1N1 Vaccines Market Size by Type
8.2.1 Asia Pacific H1N1 Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific H1N1 Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific H1N1 Vaccines Market Size by Application
8.3.1 Asia Pacific H1N1 Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific H1N1 Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific H1N1 Vaccines Market Size by Region
8.4.1 Asia Pacific H1N1 Vaccines Sales by Region
8.4.2 Asia Pacific H1N1 Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America H1N1 Vaccines Sales Breakdown by Company
9.1.1 Latin America H1N1 Vaccines Sales by Company (2017-2022)
9.1.2 Latin America H1N1 Vaccines Revenue by Company (2017-2022)
9.2 Latin America H1N1 Vaccines Market Size by Type
9.2.1 Latin America H1N1 Vaccines Sales by Type (2017-2028)
9.2.2 Latin America H1N1 Vaccines Revenue by Type (2017-2028)
9.3 Latin America H1N1 Vaccines Market Size by Application
9.3.1 Latin America H1N1 Vaccines Sales by Application (2017-2028)
9.3.2 Latin America H1N1 Vaccines Revenue by Application (2017-2028)
9.4 Latin America H1N1 Vaccines Market Size by Country
9.4.1 Latin America H1N1 Vaccines Sales by Country (2017-2028)
9.4.2 Latin America H1N1 Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa H1N1 Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa H1N1 Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa H1N1 Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa H1N1 Vaccines Market Size by Type
10.2.1 Middle East and Africa H1N1 Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa H1N1 Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa H1N1 Vaccines Market Size by Application
10.3.1 Middle East and Africa H1N1 Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa H1N1 Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa H1N1 Vaccines Market Size by Country
10.4.1 Middle East and Africa H1N1 Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa H1N1 Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Abbott H1N1 Vaccines Products and Services
11.1.5 Abbott H1N1 Vaccines SWOT Analysis
11.1.6 Abbott Recent Developments
11.2 Baxter International
11.2.1 Baxter International Corporation Information
11.2.2 Baxter International Overview
11.2.3 Baxter International H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Baxter International H1N1 Vaccines Products and Services
11.2.5 Baxter International H1N1 Vaccines SWOT Analysis
11.2.6 Baxter International Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sanofi H1N1 Vaccines Products and Services
11.3.5 Sanofi H1N1 Vaccines SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 GSK
11.4.1 GSK Corporation Information
11.4.2 GSK Overview
11.4.3 GSK H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 GSK H1N1 Vaccines Products and Services
11.4.5 GSK H1N1 Vaccines SWOT Analysis
11.4.6 GSK Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Pfizer H1N1 Vaccines Products and Services
11.5.5 Pfizer H1N1 Vaccines SWOT Analysis
11.5.6 Pfizer Recent Developments
11.6 Mitsubishi Tanabe Pharma
11.6.1 Mitsubishi Tanabe Pharma Corporation Information
11.6.2 Mitsubishi Tanabe Pharma Overview
11.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Products and Services
11.6.5 Mitsubishi Tanabe Pharma H1N1 Vaccines SWOT Analysis
11.6.6 Mitsubishi Tanabe Pharma Recent Developments
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Corporation Information
11.7.2 Hualan Biological Engineering Overview
11.7.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Hualan Biological Engineering H1N1 Vaccines Products and Services
11.7.5 Hualan Biological Engineering H1N1 Vaccines SWOT Analysis
11.7.6 Hualan Biological Engineering Recent Developments
11.8 Cipla
11.8.1 Cipla Corporation Information
11.8.2 Cipla Overview
11.8.3 Cipla H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Cipla H1N1 Vaccines Products and Services
11.8.5 Cipla H1N1 Vaccines SWOT Analysis
11.8.6 Cipla Recent Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Overview
11.9.3 Merck H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Merck H1N1 Vaccines Products and Services
11.9.5 Merck H1N1 Vaccines SWOT Analysis
11.9.6 Merck Recent Developments
11.10 Sinovac Biotech
11.10.1 Sinovac Biotech Corporation Information
11.10.2 Sinovac Biotech Overview
11.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Sinovac Biotech H1N1 Vaccines Products and Services
11.10.5 Sinovac Biotech H1N1 Vaccines SWOT Analysis
11.10.6 Sinovac Biotech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 H1N1 Vaccines Value Chain Analysis
12.2 H1N1 Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 H1N1 Vaccines Production Mode & Process
12.4 H1N1 Vaccines Sales and Marketing
12.4.1 H1N1 Vaccines Sales Channels
12.4.2 H1N1 Vaccines Distributors
12.5 H1N1 Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global H1N1 Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Vaccines
Table 3. Major Manufacturers of Intranasal Vaccines
Table 4. Major Manufacturers of Intradermal Vaccines
Table 5. Global H1N1 Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global H1N1 Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global H1N1 Vaccines Sales by Region (2017-2022) & (K Units)
Table 8. Global H1N1 Vaccines Sales Market Share by Region (2017-2022)
Table 9. Global H1N1 Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global H1N1 Vaccines Revenue Market Share by Region (2017-2022)
Table 11. Global H1N1 Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global H1N1 Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 13. Global H1N1 Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global H1N1 Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top H1N1 Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. H1N1 Vaccines Market Trends
Table 17. H1N1 Vaccines Market Drivers
Table 18. H1N1 Vaccines Market Challenges
Table 19. H1N1 Vaccines Market Restraints
Table 20. Global H1N1 Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global H1N1 Vaccines Sales Share by Manufacturers (2017-2022)
Table 22. Global H1N1 Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top H1N1 Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 24. H1N1 Vaccines Revenue Share by Manufacturers (2017-2022)
Table 25. Global H1N1 Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in H1N1 Vaccines as of 2021)
Table 27. Key Manufacturers H1N1 Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers H1N1 Vaccines Plants/Factories Distribution
Table 29. Key Manufacturers H1N1 Vaccines Area Served
Table 30. Date of Key Manufacturers Enter into H1N1 Vaccines Market
Table 31. Key Manufacturers H1N1 Vaccines Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global H1N1 Vaccines Sales (K Units) by Type (2017-2022)
Table 34. Global H1N1 Vaccines Sales Share by Type (2017-2022)
Table 35. Global H1N1 Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global H1N1 Vaccines Price (K Units) by Type (2017-2022)
Table 37. Global H1N1 Vaccines Sales (K Units) by Type (2023-2028)
Table 38. Global H1N1 Vaccines Sales Share by Type (2023-2028)
Table 39. Global H1N1 Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global H1N1 Vaccines Revenue Share by Type (2023-2028)
Table 41. Global H1N1 Vaccines Price (K Units) by Type (2023-2028)
Table 42. Global H1N1 Vaccines Sales (K Units) by Application (2017-2022)
Table 43. Global H1N1 Vaccines Sales Share by Application (2017-2022)
Table 44. Global H1N1 Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global H1N1 Vaccines Price (K Units) by Application (2017-2022)
Table 46. Global H1N1 Vaccines Sales (K Units) by Application (2023-2028)
Table 47. Global H1N1 Vaccines Sales Share by Application (2023-2028)
Table 48. Global H1N1 Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global H1N1 Vaccines Revenue Share by Application (2023-2028)
Table 50. Global H1N1 Vaccines Price (K Units) by Application (2023-2028)
Table 51. North America H1N1 Vaccines Sales by Company (2017-2022) & (K Units)
Table 52. North America H1N1 Vaccines Sales Market Share by Company (2017-2022)
Table 53. North America H1N1 Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America H1N1 Vaccines Revenue Market Share by Company (2017-2022)
Table 55. North America H1N1 Vaccines Sales by Type (2017-2022) & (K Units)
Table 56. North America H1N1 Vaccines Sales by Type (2023-2028) & (K Units)
Table 57. North America H1N1 Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America H1N1 Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America H1N1 Vaccines Sales by Application (2017-2022) & (K Units)
Table 60. North America H1N1 Vaccines Sales by Application (2023-2028) & (K Units)
Table 61. North America H1N1 Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America H1N1 Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 64. North America H1N1 Vaccines Sales by Country (2023-2028) & (K Units)
Table 65. North America H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America H1N1 Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe H1N1 Vaccines Sales by Company (2017-2022) & (K Units)
Table 68. Europe H1N1 Vaccines Sales Market Share by Company (2017-2022)
Table 69. Europe H1N1 Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe H1N1 Vaccines Revenue Market Share by Company (2017-2022)
Table 71. Europe H1N1 Vaccines Sales by Type (2017-2022) & (K Units)
Table 72. Europe H1N1 Vaccines Sales by Type (2023-2028) & (K Units)
Table 73. Europe H1N1 Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe H1N1 Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe H1N1 Vaccines Sales by Application (2017-2022) & (K Units)
Table 76. Europe H1N1 Vaccines Sales by Application (2023-2028) & (K Units)
Table 77. Europe H1N1 Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe H1N1 Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 80. Europe H1N1 Vaccines Sales by Country (2023-2028) & (K Units)
Table 81. Europe H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe H1N1 Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific H1N1 Vaccines Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific H1N1 Vaccines Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific H1N1 Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific H1N1 Vaccines Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific H1N1 Vaccines Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific H1N1 Vaccines Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific H1N1 Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific H1N1 Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific H1N1 Vaccines Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific H1N1 Vaccines Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific H1N1 Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific H1N1 Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific H1N1 Vaccines Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific H1N1 Vaccines Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific H1N1 Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific H1N1 Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America H1N1 Vaccines Sales by Company (2017-2022) & (K Units)
Table 100. Latin America H1N1 Vaccines Sales Market Share by Company (2017-2022)
Table 101. Latin America H1N1 Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America H1N1 Vaccines Revenue Market Share by Company (2017-2022)
Table 103. Latin America H1N1 Vaccines Sales by Type (2017-2022) & (K Units)
Table 104. Latin America H1N1 Vaccines Sales by Type (2023-2028) & (K Units)
Table 105. Latin America H1N1 Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America H1N1 Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America H1N1 Vaccines Sales by Application (2017-2022) & (K Units)
Table 108. Latin America H1N1 Vaccines Sales by Application (2023-2028) & (K Units)
Table 109. Latin America H1N1 Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America H1N1 Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 112. Latin America H1N1 Vaccines Sales by Country (2023-2028) & (K Units)
Table 113. Latin America H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America H1N1 Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa H1N1 Vaccines Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa H1N1 Vaccines Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa H1N1 Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa H1N1 Vaccines Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa H1N1 Vaccines Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa H1N1 Vaccines Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa H1N1 Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa H1N1 Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa H1N1 Vaccines Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa H1N1 Vaccines Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa H1N1 Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa H1N1 Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa H1N1 Vaccines Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa H1N1 Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 131. Abbott Corporation Information
Table 132. Abbott Description and Overview
Table 133. Abbott H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Abbott H1N1 Vaccines Product and Services
Table 135. Abbott H1N1 Vaccines SWOT Analysis
Table 136. Abbott Recent Developments
Table 137. Baxter International Corporation Information
Table 138. Baxter International Description and Overview
Table 139. Baxter International H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. Baxter International H1N1 Vaccines Product and Services
Table 141. Baxter International H1N1 Vaccines SWOT Analysis
Table 142. Baxter International Recent Developments
Table 143. Sanofi Corporation Information
Table 144. Sanofi Description and Overview
Table 145. Sanofi H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Sanofi H1N1 Vaccines Product and Services
Table 147. Sanofi H1N1 Vaccines SWOT Analysis
Table 148. Sanofi Recent Developments
Table 149. GSK Corporation Information
Table 150. GSK Description and Overview
Table 151. GSK H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. GSK H1N1 Vaccines Product and Services
Table 153. GSK H1N1 Vaccines SWOT Analysis
Table 154. GSK Recent Developments
Table 155. Pfizer Corporation Information
Table 156. Pfizer Description and Overview
Table 157. Pfizer H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. Pfizer H1N1 Vaccines Product and Services
Table 159. Pfizer H1N1 Vaccines SWOT Analysis
Table 160. Pfizer Recent Developments
Table 161. Mitsubishi Tanabe Pharma Corporation Information
Table 162. Mitsubishi Tanabe Pharma Description and Overview
Table 163. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Mitsubishi Tanabe Pharma H1N1 Vaccines Product and Services
Table 165. Mitsubishi Tanabe Pharma H1N1 Vaccines SWOT Analysis
Table 166. Mitsubishi Tanabe Pharma Recent Developments
Table 167. Hualan Biological Engineering Corporation Information
Table 168. Hualan Biological Engineering Description and Overview
Table 169. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Hualan Biological Engineering H1N1 Vaccines Product and Services
Table 171. Hualan Biological Engineering H1N1 Vaccines SWOT Analysis
Table 172. Hualan Biological Engineering Recent Developments
Table 173. Cipla Corporation Information
Table 174. Cipla Description and Overview
Table 175. Cipla H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Cipla H1N1 Vaccines Product and Services
Table 177. Cipla H1N1 Vaccines SWOT Analysis
Table 178. Cipla Recent Developments
Table 179. Merck Corporation Information
Table 180. Merck Description and Overview
Table 181. Merck H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 182. Merck H1N1 Vaccines Product and Services
Table 183. Merck H1N1 Vaccines SWOT Analysis
Table 184. Merck Recent Developments
Table 185. Sinovac Biotech Corporation Information
Table 186. Sinovac Biotech Description and Overview
Table 187. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 188. Sinovac Biotech H1N1 Vaccines Product and Services
Table 189. Sinovac Biotech H1N1 Vaccines SWOT Analysis
Table 190. Sinovac Biotech Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. H1N1 Vaccines Distributors List
Table 194. H1N1 Vaccines Customers List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. H1N1 Vaccines Product Picture
Figure 2. Global H1N1 Vaccines Sales Market Share by Type in 2021 & 2028
Figure 3. Intramuscular Vaccines Product Picture
Figure 4. Intranasal Vaccines Product Picture
Figure 5. Intradermal Vaccines Product Picture
Figure 6. Global H1N1 Vaccines Sales Market Share by Application in 2021 & 2028
Figure 7. Influenza Use Case
Figure 8. Meningococcal Use Case
Figure 9. Cervical Cancer Use Case
Figure 10. Pneumococcal Use Case
Figure 11. Hepatitis Use Case
Figure 12. Measles Use Case
Figure 13. Mumps Use Case
Figure 14. Rubella Use Case
Figure 15. Others Use Case
Figure 16. H1N1 Vaccines Report Years Considered
Figure 17. Global H1N1 Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global H1N1 Vaccines Market Size 2017-2028 (US$ Million)
Figure 19. Global H1N1 Vaccines Sales (2017-2022) & (K Units)
Figure 20. Global H1N1 Vaccines Market Size Market Share by Region: 2021 VS 2028
Figure 21. Global H1N1 Vaccines Sales Market Share by Region (2017-2022)
Figure 22. Global H1N1 Vaccines Sales Market Share by Region in 2021
Figure 23. Global H1N1 Vaccines Revenue Market Share by Region in 2017 VS 2021
Figure 24. Global H1N1 Vaccines Sales Share by Manufacturers in 2021
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by H1N1 Vaccines Sales in 2021
Figure 26. H1N1 Vaccines Revenue Share by Manufacturers in 2021
Figure 27. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 28. Global H1N1 Vaccines Revenue Share by Type (2017-2022)
Figure 29. Global H1N1 Vaccines Revenue Growth Rate by Type in 2017 & 2021
Figure 30. Global H1N1 Vaccines Revenue Share by Application (2017-2022)
Figure 31. Global H1N1 Vaccines Revenue Growth Rate by Application in 2017 & 2021
Figure 32. North America H1N1 Vaccines Sales Market Share by Type (2017-2028)
Figure 33. North America H1N1 Vaccines Revenue Market Share by Type (2017-2028)
Figure 34. North America H1N1 Vaccines Sales Market Share by Application (2017-2028)
Figure 35. North America H1N1 Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. North America H1N1 Vaccines Sales Share by Country (2017-2028)
Figure 37. North America H1N1 Vaccines Revenue Share by Country (2017-2028)
Figure 38. U.S. H1N1 Vaccines Revenue (2017-2028) & (US$ Million)
Figure 39. Canada H1N1 Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. Europe H1N1 Vaccines Sales Market Share by Type (2017-2028)
Figure 41. Europe H1N1 Vaccines Revenue Market Share by Type (2017-2028)
Figure 42. Europe H1N1 Vaccines Sales Market Share by Application (2017-2028)
Figure 43. Europe H1N1 Vaccines Revenue Market Share by Application (2017-2028)
Figure 44. Europe H1N1 Vaccines Sales Share by Country (2017-2028)
Figure 45. Europe H1N1 Vaccines Revenue Share by Country (2017-2028)
Figure 46. Germany H1N1 Vaccines Revenue (2017-2028) & (US$ Million)
Figure 47. France H1N1 Vaccines Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. H1N1 Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. Italy H1N1 Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. Russia H1N1 Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific H1N1 Vaccines Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific H1N1 Vaccines Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacif

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs